AU2003267906A1 - Process for preparating concentrated thrombin solutions and use in fibrin glue - Google Patents

Process for preparating concentrated thrombin solutions and use in fibrin glue

Info

Publication number
AU2003267906A1
AU2003267906A1 AU2003267906A AU2003267906A AU2003267906A1 AU 2003267906 A1 AU2003267906 A1 AU 2003267906A1 AU 2003267906 A AU2003267906 A AU 2003267906A AU 2003267906 A AU2003267906 A AU 2003267906A AU 2003267906 A1 AU2003267906 A1 AU 2003267906A1
Authority
AU
Australia
Prior art keywords
preparating
fibrin glue
thrombin solutions
concentrated thrombin
concentrated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267906A
Other languages
English (en)
Inventor
Peter Aizawa
Goran Karlsson
Stefan Winge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2003267906A1 publication Critical patent/AU2003267906A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2003267906A 2002-12-02 2003-10-06 Process for preparating concentrated thrombin solutions and use in fibrin glue Abandoned AU2003267906A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0203552A SE0203552D0 (sv) 2002-12-02 2002-12-02 Thrombin concentration
SE0203552-5 2002-12-02
PCT/SE2003/001548 WO2004050700A1 (en) 2002-12-02 2003-10-06 Process for preparating concentrated thrombin solutions and use in fibrin glue

Publications (1)

Publication Number Publication Date
AU2003267906A1 true AU2003267906A1 (en) 2004-06-23

Family

ID=20289727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267906A Abandoned AU2003267906A1 (en) 2002-12-02 2003-10-06 Process for preparating concentrated thrombin solutions and use in fibrin glue

Country Status (3)

Country Link
AU (1) AU2003267906A1 (sv)
SE (1) SE0203552D0 (sv)
WO (1) WO2004050700A1 (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO2004050700A1 (en) 2004-06-17
SE0203552D0 (sv) 2002-12-02

Similar Documents

Publication Publication Date Title
AU2003270035A1 (en) A process for reducing nitrogen containing compounds and lignin in tobacco
AU2001241614A1 (en) Fluid-activatable adhesive articles and methods
AU2002338760A1 (en) Adhesive components and process for manufacture
AU2003298951A1 (en) Methods and systems to manage machine state in virtual machine operations
AU2003277160A1 (en) Methods for tissue repair using adhesive materials
AU2003297405A1 (en) Staple fibers and processes for making same
AU2003228364A1 (en) Field-assisted fusion bonding
AU2003268334A1 (en) Interlabial absorbent article
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2003216019A1 (en) Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions.
AU2003268003A1 (en) Diamondoid-based components in nanoscale construction
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2003251400A1 (en) Preforms for acute structural edges
AU2003214798A1 (en) Laminates and processes for making same
AU2001294557A1 (en) Thrombin inhibitors
AU2003298782A1 (en) Adhesive articles, method for making and uses for same
AU2003210952A1 (en) Nitric oxide in a pathogen inactivation process
AU2002322802A1 (en) Thrombin inhibitors
AU2001281843A1 (en) Dipeptide inhibitors for the blood-clotting factor Xa
AU2003299901A1 (en) Thrombin inhibitors
AU2003268795A1 (en) Pallets and methods for manufacture and use thereof
AU2003224085A1 (en) Waveguide in porous substrates
AU2003222071A1 (en) Direct bonding methods using lithium
AU2003267906A1 (en) Process for preparating concentrated thrombin solutions and use in fibrin glue
AU2002351076A1 (en) Thrombin inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase